# A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania

> **NCT00261443** · PHASE4 · COMPLETED · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 1270 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Lithium or Valproate with placebo (PBO)
- **DRUG:** Lithium or Valproate with Aripiprazole

## Key facts

- **NCT ID:** NCT00261443
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2009-06
- **Final completion:** 2009-10
- **Target enrollment:** 1270 (ACTUAL)
- **Last updated:** 2023-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00261443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00261443, "A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00261443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*